Litcius/Paper detail

COVID-19 and Respiratory System Disorders

Shari B. Brosnahan, Annemijn H. Jonkman, Matthias C. Kugler, John S. Munger, David A. Kaufman

2020Arteriosclerosis Thrombosis and Vascular Biology179 citationsDOIOpen Access PDF

Abstract

The severe acute respiratory syndrome coronavirus-2 emerged as a serious human pathogen in late 2019, causing the disease coronavirus disease 2019 (COVID-19). The most common clinical presentation of severe COVID-19 is acute respiratory failure consistent with the acute respiratory distress syndrome. Airway, lung parenchymal, pulmonary vascular, and respiratory neuromuscular disorders all feature in COVID-19. This article reviews what is known about the effects of severe acute respiratory syndrome coronavirus-2 infection on different parts of the respiratory system, clues to understanding the underlying biology of respiratory disease, and highlights current and future translation and clinical research questions.

Topics & Concepts

Respiratory systemCoronavirusMedicineRespiratory diseaseIntensive care medicineDiseaseRespiratory failureCoronavirus disease 2019 (COVID-19)Respiratory distressDiffuse alveolar damageImmunologyLungAcute respiratory distressPathologyInfectious disease (medical specialty)Internal medicineAnesthesiaCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Respiratory Support and Mechanisms